The socioeconomic impact of inherited retinal dystrophies

Analysis

The socioeconomic impact of inherited retinal dystrophies

A cost of illness study

Deloitte Access Economics was commissioned to estimate the disease burden and economic impact of inherited retinal dystrophies in the United Kingdom and Republic of Ireland in 2019

Retina International on behalf of the IRD COUNTS consortium engaged Deloitte Access Economics to estimate the disease burden and economic impact of IRDs in the UK and RoI from a societal perspective – a cost-of-illness study. This approach involves estimating the number of people with IRDs in a base period (2019) and the costs attributable to IRDs in that period.

The socioeconomic burden of inherited retinal dystrophies (IRDs) in the United Kingdom and Republic of Ireland was estimated using best practice cost-of-illness methodology applying a prevalence approach. The analysis was based on data collected in a targeted literature review and primary (survey) data collection.

This analysis found that:

  • The overall prevalence of IRDs was estimated to be 0.03% which represented 20,814 cases in the UK and 1,522 cases in the RoI, in 2019.
  • IRDs imposed significant economic and wellbeing costs on the UK and RoI population in 2019.
  • Total costs attributable to IRDs in the UK were estimated to be £523.3 million in 2019, comprising both economic costs (£327.2 million) and wellbeing costs (£196.1 million).
  • Total costs attributable to IRDs in the RoI were estimated to be €49.5 million in 2019, comprising both economic (€33.5 million) and wellbeing costs (€16.0 million).
  • Wellbeing costs comprised the largest share of total costs, followed by productivity costs.
  • Of the ten IRDs within scope, retinitis pigmentosa (RP) incurred the greatest proportion of total costs, followed by Usher syndrome and Stargardt disease.
  • Of those people surveyed as an input to this analysis, the majority of persons living with an IRD (73.2%) and the parents of children (under 18) living with an IRD (75%) were frustrated by the lack of awareness and support for IRDs.

Published: September 2019

  • Contact us
  • Submit RFP
  • Our solutions

    Progress your business growth and development

    Take a look at the products and services we offer.

    Deloitte Access Economics

    Deloitte Access Economics offers a full suite of economic advisory services including economic forecasting, modelling, analysis and advisory services to help our clients plan for the future, understand the implications of major decisions, and navigate the complexities of economic policy.

    Health economics and social policy

    A dedicated practice of professionals with a passion for making an impact in the health and social services sector.

    Health service planning and commissioning

    Deloitte Access Economics offers health service planning and commissioning to help clients match health resources to healthcare needs and unlock improvements in healthcare outcomes for our clients' catchment populations.

  • Our latest reports and thought leadership
Did you find this useful?